Overview
AOD-9604 is classified as a gh fragment peptide. Fat loss without GH side effects.
Mimics GH fat-burning domain. Stimulates lipolysis and inhibits lipogenesis by acting on beta-3 adrenergic receptors in fat tissue, without binding to the GH receptor.
Also known as: Advanced Obesity Drug 9604
Category
GH Fragment
Half-Life
1h
Route
SubQ
FDA Status
Not Approved
How Does AOD-9604 Work?
Mimics GH fat-burning domain. Stimulates lipolysis and inhibits lipogenesis by acting on beta-3 adrenergic receptors in fat tissue, without binding to the GH receptor.
At the molecular level, AOD-9604 operates through pathways characteristic of the GH Fragment class, interacting with target receptors and downstream signaling cascades to produce its observed effects.
Published Research
The following studies are indexed from PubMed and peer-reviewed journals:
[1]AOD-9604 lipolysis stimulation in preclinical models
Ng et al. demonstrate AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue without affecting IGF-1 or glucose tolerance.
Evidence: preclinical[2]AOD-9604 clinical safety six randomized controlled trials
Heffernan et al.: Pooled analysis of 6 RCTs showing AOD-9604 is well-tolerated with a safety profile similar to placebo despite limited efficacy signals.
Evidence: moderate[3]AOD-9604 Phase IIb trial short-term fat reduction
12-week Phase IIb trial: 1mg/day AOD-9604 produced 2.6 kg weight loss vs 0.8 kg placebo, with reductions in abdominal fat and improved lipid profiles.
Evidence: moderateSafety Profile
Research-only. Received GRAS status from FDA as food supplement ingredient. Banned by WADA. Phase 3 trial discontinued due to insufficient efficacy.
| Side Effect | Incidence | Severity |
|---|---|---|
| Injection site reaction | ~5% of users | mild |
| Mild nausea | ~3% of users | mild |
Sourcing AOD-9604 for Research
If you're looking to source AOD-9604 for laboratory research, our vendor directory compares pricing, purity testing, and COA verification from independently vetted suppliers.
Disclosure: PeptiDex may earn a commission from affiliate links. This does not affect our recommendations.
Full Research Profile
AOD-9604 — dosing, interactions, timelines & more
Comprehensive compound profile with sourcing information, stacking synergies, and outcome timelines.